Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

4.13
Delayed Data
As of Oct 18
 -0.62 / -13.05%
Today’s Change
0.67
Today|||52-Week Range
6.96
+29.73%
Year-to-Date

Today’s Trading

Previous close4.75
Today’s open4.75
Day’s range4.08 - 4.76
Volume12,835,187
Average volume (3 months)5,634,365
Market cap$545.7M
Dividend yield--
Data as of 10/18/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-165.07%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratio2.8
Price/Sales1.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ZYMEZymeworks Inc+0.01+0.11%
ALBOAlbireo Pharma Inc+0.39+1.47%
MDGLMadrigal Pharmaceuti...+0.51+1.08%
CMRXChimerix Inc-0.27-5.23%
Data as of 10/18/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$174.8M
Annual profit (last year)$125.7M
Net profit margin71.91%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael E. Castagna
Chief Financial Officer &
Chief Accounting Officer
Steven Binder
Corporate headquarters
Westlake Village, California

Forecasts